Home/Benitec Biopharma/Sophie Mukadam
SM

Sophie Mukadam

Chief Operating Officer

Benitec Biopharma

Benitec Biopharma Pipeline

DrugIndicationPhase
BB-301Oculopharyngeal Muscular Dystrophy (OPMD)Phase 1b/2a